Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap

Geographic Differences in Time to Culture Conversion in Liquid Media: Tuberculosis Trials Consortium Study 28. Culture Conversion Is Delayed in Africa

(2011) William R. Mac Kenzie et al.   PLoS One

Global tuberculosis drug development pipeline: the need and the reality

(2010) Zhenkun Ma et al.   LANCET

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

(2010) Robert S Wallis et al.   LANCET

Early clinical development of anti-tuberculosis drugs: Science, statistics and sterilizing activity

(2010) Geraint R. Davies   TUBERCULOSIS

Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease

(2009) Stephen D Lawn et al.   AIDS

Biomarkers of Disease Activity, Cure, and Relapse in Tuberculosis

(2009) T. Mark Doherty et al.   CLINICS IN CHEST MEDICINE

Surrogate and Mediating Endpoints: Current Status and Future Directions

(2009) Ross L. Prentice   JNCI-Journal of the National Cancer Institute

Biomarkers for tuberculosis disease activity, cure, and relapse

(2009) Robert S Wallis et al.   LANCET INFECTIOUS DISEASES

Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods

(2009) Clare Green et al.   LANCET INFECTIOUS DISEASES

Biomarkers for TB treatment response: Challenges and future strategies

(2008) Gerhard Walzl et al.   JOURNAL OF INFECTION

Banking of Biological Fluids for Studies of Disease-associated Protein Biomarkers

(2008) Anne-Sofie Schrohl et al.   MOLECULAR & CELLULAR PROTEOMICS

Using Animal Models to Develop New Treatments for Tuberculosis

(2008) Eric Nuermberger   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE